Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Testosterone + Carboplatin in Men With Advanced Prostate Cancer

NCT03522064 is registered in ClinicalTrials.gov with St Vincent's Hospital, Sydney as lead sponsor.

NCT NCT03522064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03522064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Testosterone + Carboplatin in Men With Advanced Prostate Cancer
Lead sponsor
St Vincent's Hospital, Sydney
Phase
Phase 2
Overall status
Recruiting
Start date
July 30, 2018
Completion date
December 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

castration-resistant prostate cancer, homologous recombination deficiency